Get the Stockscreener App
88.95
0.33%
0.29
Boston Scientific Corp stock is traded at $88.95, with a volume of 14.25M.
It is up +0.33% in the last 24 hours and down -1.35% over the past month.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
See More
Previous Close:
$88.66
Open:
$88
24h Volume:
14.25M
Relative Volume:
2.59
Market Cap:
$131.10B
Revenue:
$15.91B
Net Income/Loss:
$1.79B
P/E Ratio:
108.48
EPS:
0.82
Net Cash Flow:
$1.89B
1W Performance:
-1.29%
1M Performance:
-1.35%
6M Performance:
+15.52%
1Y Performance:
+61.79%
1-Day Range:
$87.25
$89.67
1-Week Range:
$87.25
$91.59
52-Week Range:
$54.95
$91.93
Boston Scientific Corp Stock (BSX) Company Profile
Name
Boston Scientific Corp
Sector
Industry
Phone
508-683-4000
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
88.95 | 131.10B | 15.91B | 1.79B | 1.89B | 1.21 |
|
ABT
Abbott Laboratories
|
114.23 | 198.13B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
364.60 | 138.99B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
81.03 | 103.90B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.81 | 44.12B | 6.60B | 4.16B | 490.10M | 6.93 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-18-24 | Downgrade | Needham | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Feb-01-24 | Upgrade | Mizuho | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-22-22 | Initiated | Mizuho | Neutral |
| Dec-20-22 | Resumed | Citigroup | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-27-22 | Upgrade | Needham | Hold → Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| May-26-21 | Downgrade | Needham | Buy → Hold |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-22-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-01-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Buy |
| Dec-30-19 | Reiterated | Cowen | Outperform |
| Dec-19-19 | Downgrade | Needham | Strong Buy → Buy |
| Sep-05-19 | Resumed | JP Morgan | Overweight |
| Sep-03-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Oct-02-18 | Reiterated | Morgan Stanley | Overweight |
| Sep-07-18 | Reiterated | Needham | Strong Buy |
| Sep-04-18 | Upgrade | Jefferies | Hold → Buy |
| Jul-06-18 | Reiterated | Needham | Strong Buy |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Apr-26-18 | Reiterated | Needham | Strong Buy |
View All
Boston Scientific Corp Stock (BSX) Latest News
Boston Scientific Corp. stock rises Friday, still underperforms market - MarketWatch
Truist maintains Buy on Boston Scientific with $110 target - Investing.com
Boston Scientific Updates Instructions for Cryoablation Balloons After Reports Of Severe Injuries - Benzinga
Should You Be Adding Boston Scientific (NYSE:BSX) To Your Watchlist Today? - Yahoo Finance
Principal Financial Group Inc. Buys 111,724 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Pain Management Devices Market May See a Big Move | Medtronic, Boston Scientific, LivaNova - openPR
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
All You Need to Know About Boston Scientific (BSX) Rating Upgrade to Buy - Yahoo Finance
Boston Scientific updates instructions for cryoablation catheters after reported deaths - Mass Device
Boston Scientific price target raised to $110 from $100 at Truist - Yahoo Finance
Boston Scientific updates cryoablation catheter instructions after 4 death reports - Yahoo Finance
FDA classifies recall of Boston Scientific catheters as 'most serious' - Reuters.com
FDA classifies recall of Boston Scientific catheters as 'most serious' By Reuters - Investing.com
Boston Scientific shares target increased, holds Buy on growth prospects - Investing.com
Boston Scientific (NYSE:BSX) Price Target Raised to $110.00 - MarketBeat
Boston Scientific (BSX) Stock Moves -0.03%: What You Should Know - Yahoo Finance
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Boston Scientific recalls Accolade pacemakers tied to 2 deaths - Yahoo Finance
Boston Scientific warns on potential need to replace Accolade pacemaker devices early - Mass Device
Boston Scientific has a new Peripheral Interventions leader in EMEA - Mass Device
Sanctuary Advisors LLC Sells 6,069 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific's SWOT analysis: medtech giant's stock poised for growth - Investing.com
Wilmington Savings Fund Society FSB Makes New Investment in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Investing in Boston Scientific (NYSE:BSX) three years ago would have delivered you a 121% gain - Yahoo Finance
Short Interest in Boston Scientific Co. (NYSE:BSX) Grows By 11.2% - MarketBeat
Jim Cramer on Boston Scientific Corporation (BSX): ‘A Superior Company’ - Yahoo Finance
Boston Scientific Corp. stock outperforms competitors despite losses on the day - MarketWatch
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? - Zacks Investment Research
Oddo BHF Asset Management Sas Buys New Stake in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Shares Sold by Franklin Resources Inc. - MarketBeat
Boston Scientific best idea at TD Cowen, lifts PT by $10 - Investing.com
Boston Scientific shares target lifted, buy rating on robust performance - Investing.com
Innovations and Buyouts Support BSX Stock Amid Macroeconomic Woes - Yahoo Finance
Boston Scientific Co. (NYSE:BSX) Shares Sold by Toronto Dominion Bank - MarketBeat
Teachers Retirement System of The State of Kentucky Sells 150,603 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific (BSX) Ascends But Remains Behind Market: Some Facts to Note - Yahoo Finance
Boston Scientific Corp. stock rises Wednesday, still underperforms market - MarketWatch
TCW Group Inc. Sells 147,999 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific CMO Discuss Solutions for Health Inequality on Today's Marketplace - Quantisnow
Boston Scientific CMO Discuss Solutions for Health Inequality on Today's Marketplace – Company Announcement - Financial Times
Brown Financial Advisors Has $1.04 Million Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Vestcor Inc Has $3.38 Million Stake in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Why Boston Scientific Corporation (NYSE:BSX) Could Be Worth Watching - Yahoo Finance
Cardiac Resynchronization Therapy (CRT) Market Insights, Competitive Landscape and Market Forecast 2024-2030 - GlobeNewswire Inc.
Boston Scientific Co. (NYSE:BSX) Stock Holdings Decreased by Nomura Asset Management Co. Ltd. - MarketBeat
Boston Scientific Co. (NYSE:BSX) Position Increased by Zacks Investment Management - MarketBeat
National Bank of Canada FI Increases Stock Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
United Services Automobile Association Sells 7,295 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Worldquant Millennium Advisors LLC Makes New $9.04 Million Investment in Boston Scientific Co. (NYSE:BSX) - MarketBeat
A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX) - Yahoo Canada Finance
Layoffs in medtech: These companies recently reduced their workforce - Mass Device
Boston Scientific Corp Stock (BSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):